Last quarter (Q4 2023), Valeo Pharma's total revenue was C$13.11M, an increase of 115.84% from the same quarter last year. In Q4, Valeo Pharma's net income was C$-9.24M. See Valeo Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Oct 23	Oct 22	Oct 21	Oct 20	Oct 19
Total Revenue	C$ 53.91M	C$ 53.91M	C$ 27.75M	C$ 13.56M	C$ 7.47M	C$ 6.58M
Cost of Revenue	C$ 40.83M	C$ 40.83M	C$ 21.02M	C$ 9.60M	C$ 6.09M	C$ 5.18M
Gross Profit	C$ 13.08M	C$ 13.08M	C$ 6.72M	C$ 3.96M	C$ 1.38M	C$ 1.40M
Operating Expense	C$ 30.15M	C$ 30.15M	C$ 25.15M	C$ 16.65M	C$ 5.68M	C$ 5.14M
Operating Income	C$ -17.07M	C$ -17.07M	C$ -18.42M	C$ -12.69M	C$ -4.30M	C$ -3.74M
Net Non Operating Interest Income Expense	C$ -10.07M	C$ -10.07M	C$ -6.33M	C$ 1.39M	C$ 613.00K	C$ -134.00K
Other Income Expense	C$ -149.00K	C$ -149.00K	C$ -315.00K	C$ -153.00K	C$ 152.00K	C$ 256.00K
Pretax Income	C$ -27.81M	C$ -27.81M	C$ -26.92M	C$ -14.23M	C$ -4.76M	C$ -3.62M
Tax Provision	-	-	C$ -1.17M	-	-	C$ 0.00
Earnings From Equity Interest Net Of Tax	C$ -200.00K	C$ -200.00K	C$ -142.00K	-	-	-
Net Income Common Stockholders	C$ -27.81M	C$ -27.81M	C$ -25.75M	C$ -14.23M	C$ -4.76M	C$ -3.62M
Basic EPS	C$ -0.33	C$ -0.32	C$ -0.32	C$ -0.20	C$ -0.08	C$ -0.07
Diluted EPS	C$ -0.33	C$ -0.32	C$ -0.32	C$ -0.20	C$ -0.08	C$ -0.07
Basic Average Shares	C$ 344.47M	C$ 86.12M	C$ 80.86M	C$ 69.93M	C$ 57.91M	C$ 49.59M
Diluted Average Shares	C$ 344.47M	C$ 86.12M	C$ 80.86M	C$ 69.93M	C$ 57.91M	C$ 49.59M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 50.85M	-	C$ 46.17M	C$ -26.25M	C$ -11.77M	C$ 10.31M
Net Income From Continuing And Discontinued Operation	C$ -27.81M	C$ -27.81M	C$ -25.75M	C$ -14.23M	C$ -4.76M	C$ -3.62M
Normalized Income	C$ -20.44M	C$ -20.44M	C$ -26.87M	C$ -10.21M	C$ -3.46M	C$ -3.62M
Interest Expense	-	-	-	-	-	C$ 110.00K
EBIT	C$ -17.58M	C$ -17.58M	C$ -20.42M	C$ -12.88M	C$ -4.16M	C$ -3.50M
EBITDA	C$ -14.96M	C$ -14.96M	C$ -19.00M	C$ -12.13M	C$ -3.74M	C$ -3.37M

Currency in CAD

Valeo Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing